DCAF7 and cancer: This convergence of genetic lesions, DNA‐ and RNA‐level epigenetic alterations strongly suggests that diverse oncogenic pressures co‐opt DCAF7 to support malignant growth and highlights its potential utility as an integrated genomic–epigenomic biomarker across cancer types.